CSI Market
Sign In | Register

Halozyme Therapeutics Inc (HALO) Annual Balance Sheets

Annual · GAAP · USD millions
Access HALO quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Halozyme Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent133.82
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments133.00
Accounts receivable0.00
Inventories176.48
Other Current Assets450.27
Prepaid Expense And Other Assets Current64.64
Total Current Assets825.21
Goodwill net580.36
Intangible Assets981.47
Long-term investments2.60
Other Assets, Noncurrent138.29
Debt Securities Available For Sale Excluding Accrued Interest Current9.00
Accounts Receivable And Contract With Customer Asset After Allowance For Credit Loss Current441.27
Prepaid Expense And Other Assets Noncurrent53.55
Total Assets2,525.32
Liabilities
Accounts Payable, Current AC20.90
Accrued Liabilities, Current AC156.19
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.00
Total Current Liabilities177.09
Long-term debt2,142.63
Total Long-term Debt2,142.63
Other liabilities, Noncurrent156.79
Contract With Customer Liability Current-
Contract With Customer Liability Noncurrent-
Total Liabilities2,476.51
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock12.00
Retained Earnings / Accumulated Deficit54.79
Other Equity-18.09
Common Stockholder's Equity48.81
Preferred Stockholder's Equity0.00
Total Stockholder's Equity48.81
Liabilities & Stockholder's Equity2,525.32
4 historic quarters locked

Sign in to unlock the full Halozyme Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Halozyme Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: halo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001159036-26-000024

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License